137 related articles for article (PubMed ID: 37318099)
1. Reprogramming of the tumor microenvironment using a PCN-224@IrNCs/D-Arg nanoplatform for the synergistic PDT, NO, and radiosensitization therapy of breast cancer and improving anti-tumor immunity.
Zou YM; Li RT; Yu L; Huang T; Peng J; Meng W; Sun B; Zhang WH; Jiang ZH; Chen J; Chen JX
Nanoscale; 2023 Jun; 15(25):10715-10729. PubMed ID: 37318099
[TBL] [Abstract][Full Text] [Related]
2. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy.
Zhen W; Weichselbaum RR; Lin W
Adv Mater; 2023 May; 35(21):e2206370. PubMed ID: 36524978
[TBL] [Abstract][Full Text] [Related]
4. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers-Mediated Photodynamic Therapy.
Yu Q; Li X; Wang J; Guo L; Huang L; Gao W
Small; 2024 Apr; 20(16):e2305708. PubMed ID: 38018311
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer.
He H; Liu L; Liang R; Zhou H; Pan H; Zhang S; Cai L
Acta Biomater; 2020 Mar; 104():188-197. PubMed ID: 31945508
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment pH-responsive pentagonal gold prism-based nanoplatform for multimodal imaging and combined therapy of castration-resistant prostate cancer.
Tan H; Liu Y; Hou N; Cui S; Liu B; Fan S; Yu G; Han C; Zheng D; Li W; Liu Y; Xu B; Wang Z; Cui D
Acta Biomater; 2022 Mar; 141():408-417. PubMed ID: 35032718
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer.
Wu H; Du X; Xu J; Kong X; Li Y; Liu D; Yang X; Ye L; Ji J; Xi Y; Zhai G
Acta Biomater; 2023 Feb; 157():551-565. PubMed ID: 36513248
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Ca
Zhu J; Jiao A; Li Q; Lv X; Wang X; Song X; Li B; Zhang Y; Dong X
Acta Biomater; 2022 Jan; 137():252-261. PubMed ID: 34653696
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic Upconversion Nanoplatform Synergizes Photodynamic Therapy and Enhanced Radiotherapy against Tumor Metastasis.
Zhou D; Gao Y; Yang Z; Wang N; Ge J; Cao X; Kou D; Gu Y; Li C; Afshari MJ; Zhang R; Chen C; Wen L; Wu S; Zeng J; Gao M
ACS Appl Mater Interfaces; 2023 Jun; 15(22):26431-26441. PubMed ID: 37219450
[TBL] [Abstract][Full Text] [Related]
13. Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy.
Chen Y; Shu X; Guo JY; Xiang Y; Liang SY; Lai JM; Zhou JY; Liu LH; Wang P
J Control Release; 2024 Mar; 367():248-264. PubMed ID: 38272398
[TBL] [Abstract][Full Text] [Related]
14. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation.
Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y
Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328
[TBL] [Abstract][Full Text] [Related]
15. Near infrared light triggered ternary synergistic cancer therapy via L-arginine-loaded nanovesicles with modification of PEGylated indocyanine green.
Wang K; Jiang L; Qiu L
Acta Biomater; 2022 Mar; 140():506-517. PubMed ID: 34902616
[TBL] [Abstract][Full Text] [Related]
16. A multi-responsive Au NCs@PMLE/Ca
Yang Y; Wang P; Cheng H; Cheng Y; Zhao Z; Xu Y; Shen Y; Zhu M
Nanoscale; 2022 May; 14(19):7372-7386. PubMed ID: 35535969
[TBL] [Abstract][Full Text] [Related]
17. A tumor microenvironment responsive biodegradable CaCO
Liu Y; Pan Y; Cao W; Xia F; Liu B; Niu J; Alfranca G; Sun X; Ma L; de la Fuente JM; Song J; Ni J; Cui D
Theranostics; 2019; 9(23):6867-6884. PubMed ID: 31660074
[TBL] [Abstract][Full Text] [Related]
18. Tumor targeted self-synergistic nanoplatforms for arsenic-sensitized photodynamic therapy.
Yuan P; Fan GL; Zhao LP; Liu LS; Deng FA; Jiang XY; Hu AH; Yu XY; Chen AL; Cheng H; Li SY
Acta Biomater; 2020 Nov; 117():349-360. PubMed ID: 33010514
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.
Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C
Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179
[TBL] [Abstract][Full Text] [Related]
20. Grade-targeted nanoparticles for improved hypoxic tumor microenvironment and enhanced photodynamic cancer therapy.
Tao YK; Hou XY; Gao H; Zhang X; Zuo FM; Wang Y; Li XX; Jiang G
Nanomedicine (Lond); 2021 Feb; 16(3):221-235. PubMed ID: 33533660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
